Menthol, after topical application, causes a feeling of coolness due to stimulation of ‘cold’ receptors by inhibiting Ca11 currents of neuronal membranes. Since Ca11 channel blockers are endowed with analgesic properties, the aim of the present study was to investigate the potential antinociceptive effect of menthol. (2)-Menthol produced a dose-dependent increase in the pain threshold in the mouse hot-plate (3–10 mg kg21 p.o.) and abdominal constriction (3–10 mg kg21 p.o.; 10 mg per mouse intracerebroventricularly (i.c.v.)) tests. The antinociceptive effect of (2)-menthol was antagonised by the unselective opioid antagonist naloxone and by the selective k-antagonist nor-NBI. Conversely, CTOP (m-antagonist), 7-benzylidenenal-trexone (d1 antagonist) and naltriben (d2 antagonist) did not prevent (2)-menthol antinociception. In both tests, (1)-menthol (10–50 mg kg21 p.o.; 10–30 mg per mouse i.c.v.) was unable to modify the pain threshold. These results indicate that (2)-menthol is endowed with analgesic properties mediated through a selective activation of kopioid receptors.

MENTHOL: A NATURAL ANALGESIC COMPOUND / N. GALEOTTI; L. DI CESARE MANNELLI; G. MAZZANTINI; A. BARTOLINI; C. GHELARDINI. - In: NEUROSCIENCE LETTERS. - ISSN 0304-3940. - STAMPA. - 322(2002), pp. 145-148. [10.1016/S0304-3940(01)02527-7]

MENTHOL: A NATURAL ANALGESIC COMPOUND

GALEOTTI, NICOLETTA;DI CESARE MANNELLI, LORENZO;BARTOLINI, ALESSANDRO;GHELARDINI, CARLA
2002

Abstract

Menthol, after topical application, causes a feeling of coolness due to stimulation of ‘cold’ receptors by inhibiting Ca11 currents of neuronal membranes. Since Ca11 channel blockers are endowed with analgesic properties, the aim of the present study was to investigate the potential antinociceptive effect of menthol. (2)-Menthol produced a dose-dependent increase in the pain threshold in the mouse hot-plate (3–10 mg kg21 p.o.) and abdominal constriction (3–10 mg kg21 p.o.; 10 mg per mouse intracerebroventricularly (i.c.v.)) tests. The antinociceptive effect of (2)-menthol was antagonised by the unselective opioid antagonist naloxone and by the selective k-antagonist nor-NBI. Conversely, CTOP (m-antagonist), 7-benzylidenenal-trexone (d1 antagonist) and naltriben (d2 antagonist) did not prevent (2)-menthol antinociception. In both tests, (1)-menthol (10–50 mg kg21 p.o.; 10–30 mg per mouse i.c.v.) was unable to modify the pain threshold. These results indicate that (2)-menthol is endowed with analgesic properties mediated through a selective activation of kopioid receptors.
322
145
148
N. GALEOTTI; L. DI CESARE MANNELLI; G. MAZZANTINI; A. BARTOLINI; C. GHELARDINI
File in questo prodotto:
File Dimensione Formato  
68.mentolo Neurosci Lett.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: DRM non definito
Dimensione 126.94 kB
Formato Adobe PDF
126.94 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2158/15792
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 268
  • ???jsp.display-item.citation.isi??? 238
social impact